Patients with chemotherapy needs after minimally invasive pituitary tumor surgery can start chemotherapy within one month. Common chemotherapeutic agents used to treat pituitary tumors are temozolomide and bromocriptine.
Temozolomide becomes an antitumor active metabolite after oral administration, conversion and hydrolysis, thus inducing apoptosis of tumor cells.
Not all patients need chemotherapy after minimally invasive pituitary tumor surgery. Aggressive pituitary adenomas and patients who still have a considerable volume of residual after surgery can be treated with chemotherapeutic drugs such as temozolomide and bromocriptine, etc. It takes a certain amount of time for patients to recover from the surgery, but the exact recovery time varies from person to person, and most of the patients can start the chemotherapy within 1 month after the surgery.
It is recommended that patients actively cooperate with the doctor and choose the appropriate treatment plan and treatment time according to the doctor’s instructions.